Grant: Engage Plus Grants Program
University of Guelph
$12,134.00
Mapping interactions between Phytoglycogen and active compounds for biomedical applications
FY 2019-20
Summary
Mirexus Biotechnologies Inc. is an emerging Canadian company that has developed a novel biomaterialextracted from corn, called phytoglycogen. This all-natural biomaterial has unique properties that enable it tooutperform human-made (i.e, synthetic) molecules that are currently used in pharmaceuticals, and skin care andnatural health products. Specifically, phytoglycogen is non-toxic, can interact with and envelop other smallmolecules, and can enter into our cells; therefore, it can be used as a safe ""delivery system."" For example, it canbe used to shuttle medications into cells that they would not have otherwise been able to enter. However,before phytoglycogen can be used for this purpose, more needs to be known about how it interacts with othersmall molecules.A research team led by Physics Professor Dr. Vladimir Ladizhansky proposes to design a new set of screeningtests that take advantage of the advanced molecular imaging techniques (i.e., Nuclear Magnetic Resonance)available at the University of Guelph. They aim to use these tests to quickly and accurately find out howstrongly phytoglycogen interacts with molecules of interest, and to determine the specific structural propertiesthat enable other molecules to interact with phytoglycogen in the desired ways.The novel methods designed in this project, and the knowledge that they will enable, are essential; theyrepresent the critical first step that must be completed before new phytoglycogen-based products can bedeveloped. The knowledge gained will enable Mirexus Biotechnologies Inc. to focus product development onthe molecules that are most likely to interact with phytoglycogen. It will also enable them to design newversions of phytoglycogen that can interact with a wider spectrum of bioactive molecules. Ultimately, theproposed research will enable Mirexus Biotechnologies Inc. to develop new products, enter new markets,increase revenue, and create new jobs in research and development, as well as manufacturing and sales-allwhile providing safer and more effective beauty and healthcare products for Canadians.
Program
Engage Plus Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
538817-2019
Name nom
Ladizhansky, Vladimir
Department département
Physics
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
12134
Program id
EGP2
Program name en
Engage Plus Grants Program
Program name fr
Programme de subvention d'engagement partenarial Plus
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3500
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Analytical chemistry
Research subject fr
Chimie analytique
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Mapping interactions between Phytoglycogen and active compounds for biomedical applications
Keyword
NSERC
Application summary
Mirexus Biotechnologies Inc. is an emerging Canadian company that has developed a novel biomaterialextracted from corn, called phytoglycogen. This all-natural biomaterial has unique properties that enable it tooutperform human-made (i.e, synthetic) molecules that are currently used in pharmaceuticals, and skin care andnatural health products. Specifically, phytoglycogen is non-toxic, can interact with and envelop other smallmolecules, and can enter into our cells; therefore, it can be used as a safe ""delivery system."" For example, it canbe used to shuttle medications into cells that they would not have otherwise been able to enter. However,before phytoglycogen can be used for this purpose, more needs to be known about how it interacts with othersmall molecules.A research team led by Physics Professor Dr. Vladimir Ladizhansky proposes to design a new set of screeningtests that take advantage of the advanced molecular imaging techniques (i.e., Nuclear Magnetic Resonance)available at the University of Guelph. They aim to use these tests to quickly and accurately find out howstrongly phytoglycogen interacts with molecules of interest, and to determine the specific structural propertiesthat enable other molecules to interact with phytoglycogen in the desired ways.The novel methods designed in this project, and the knowledge that they will enable, are essential; theyrepresent the critical first step that must be completed before new phytoglycogen-based products can bedeveloped. The knowledge gained will enable Mirexus Biotechnologies Inc. to focus product development onthe molecules that are most likely to interact with phytoglycogen. It will also enable them to design newversions of phytoglycogen that can interact with a wider spectrum of bioactive molecules. Ultimately, theproposed research will enable Mirexus Biotechnologies Inc. to develop new products, enter new markets,increase revenue, and create new jobs in research and development, as well as manufacturing and sales-allwhile providing safer and more effective beauty and healthcare products for Canadians.